Buys
Open market- Shares
- +1,538,462
- Avg price
- $1.30
- Total value
- +$2,000,001
Invus Global Management, LLC - Director, 10%+ Owner at LEXICON PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Director, 10%+ Owner
- Issuer ticker
- LXRX on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Invus Global Management, LLC in LEXICON PHARMACEUTICALS, INC.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +1,538,462
- Share %
- 100%
- Total value
- +$2,000,001
Reported holdings for Invus Global Management, LLC in LEXICON PHARMACEUTICALS, INC.
Form 4 holding
Director, 10%+ Owner
LEXICON PHARMACEUTICALS, INC.
- Security class
- Series B Convertible Preferred Stock
- Shares / value
- 367,145
- Estimated value
- $23,864,432
- Report date
- 02 Feb 2026
- Price
- $65.00
- Ownership
- Indirect
Form 4 holding
Director, 10%+ Owner
LEXICON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 1,538,462
- Estimated value
- $2,000,000
- Report date
- 02 Feb 2026
- Price
- $1.30
- Ownership
- Indirect
Transaction history for Invus Global Management, LLC in LEXICON PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.